Cell Therapy Administration

Delivering Discovery: Cell Therapy Administration in the Clinical Research Setting

This accredited, on-demand educational activity is divided into five independent modules designed to equip clinical research professionals with the knowledge and tools to effectively manage and support cell therapy trials. Through expert-led presentations, learners will explore the evolution of cell therapy, operational and coordination challenges, biosafety considerations, and financial planning strategies. The activity supports interdisciplinary collaboration and aims to enhance the delivery of innovative therapies in clinical research settings.

Term of Approval
Release Date: May 1, 2026
Expiration Date: April 30, 2027

Upon completion of these enduring material modules, the participant should be better able to:

Enhance foundational knowledge of cellular therapy.
Develop operational competencies for managing cell therapy trials.
Strengthen interdisciplinary coordination and communication.
Apply financial and regulatory considerations in trial planning.

In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Nebraska Medicine. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

How to Receive Credit

To earn credit for this activity, you must:

Complete the activity registration (no fee required)
View the selected module(s) in their entirety
Complete the post-test for each module
Submit the evaluation for each module

Your certificate will be available for download or printing in your UNMC MyCCE account under Certificates & Transcripts.

Accessing the Activity

Click the module title below to review continuing education information
Click Begin On-Demand Activity to proceed to registration
Complete registration, then select View Content to access the module

Modules

Introduction to Cell Therapy: How It Started and Where It's Going
Matthew Lunning, DO, FACP
Biologic Production Facility Considerations
Scott Koepsell, MD, PhD
Cellular Therapy in Research: Coordinator Considerations
Amy Fitzgerald, BSN, RN, and Sarah Snook, BSN, RN
Institutional Biosafety Committee Considerations
Jenna McKenzie, PhD
Minimizing Financial Risk in Cell Therapy Clinical Trials
Veronica Hernandez, CPC-A; Lisa Hughes-Potter, BSN, RN, OCN; Toree Pruett; and Lara Uphoff, MPH

Questions?

Please email Tori Greenlee.